Department of Ophtalmology, Zhongshan Torch Development Zone People's Hospital, Zhongshan 528437, Guangdong Province, China.
Comput Math Methods Med. 2022 Jun 15;2022:7130422. doi: 10.1155/2022/7130422. eCollection 2022.
To systematically evaluate the efficacy, safety, recovery speed, and long-term visual quality of excimer laser corneal refractive surgery and to provide evidence-based medicine for the promotion and use of excimer laser corneal refractive surgery.
Randomized controls on excimer laser refractive surgery in Web of science, PubMed, EMBASE, ScienceDirect, Cochrane Library, China Knowledge Network (CNKI), China VIP Database, Wan Fang Database, and China Biomedical Literature Database (CBM) were searched by the computer. Randomized controlled trial (RCT) data were extracted independently by two researchers, and the risk of bias of each included RCT was assessed according to the Cochrane Handbook 5.1.0 criteria. Meta-analysis of the collected data was performed using RevMan5.4 statistical software.
In the end, 9 high-quality literatures were included, with a total of 4366 samples, and meta-analysis was used. There was no significant difference in uncorrected visual acuity WMD after excimer laser keratorefractive surgery, but there was a statistically significant difference in WMD in the safety of excimer laser keratorefractive surgery. The results of uncorrected visual acuity (close) indicated the following: Chi = 13.56, DF = 5, = 0.02, and I = 100%; the results of uncorrected visual acuity (distance) indicated the following: Chi = 34.44, DF =5 ( < 00000), and I = 85%; the results of best corrected visual acuity (myopia) indicated the following: Chi = 0.65, DF = 3, = 088 > 0.05, and I = 0%; the results of best corrected visual acuity (hyperopia) indicated the following: Chi = 1.80, DF = 3, = 0.61 > 0.05, and I = 0%.
Excimer laser corneal refractive surgery is safe and effective, with faster recovery and better long-term visual acuity treatment effect. However, more studies and follow-up with higher methodological quality and longer intervention time are needed for further validation.
系统评价准分子激光角膜屈光手术的疗效、安全性、恢复速度和长期视觉质量,为准分子激光角膜屈光手术的推广应用提供循证医学证据。
计算机检索 Web of science、PubMed、EMBASE、ScienceDirect、Cochrane Library、中国知网(CNKI)、维普数据库、万方数据库、中国生物医学文献数据库(CBM)中关于准分子激光屈光手术的随机对照试验,由 2 名研究者独立提取资料,并按照 Cochrane 手册 5.1.0 偏倚风险评估标准评价纳入研究的偏倚风险,采用 RevMan5.4 统计软件进行数据合并。
最终纳入 9 篇高质量文献,共计 4366 例样本,进行 Meta 分析。准分子激光角膜屈光手术后未矫正视力的 WMD 差异无统计学意义,但在安全性方面的 WMD 差异有统计学意义。未矫正视力(近距)的结果为:Chi²=13.56,DF=5, =0.02,I²=100%;未矫正视力(远距)的结果为:Chi²=34.44,DF=5( <0.00000),I²=85%;最佳矫正视力(近视)的结果为:Chi²=0.65,DF=3, =0.88 >0.05,I²=0%;最佳矫正视力(远视)的结果为:Chi²=1.80,DF=3, =0.61 >0.05,I²=0%。
准分子激光角膜屈光手术安全有效,恢复速度更快,长期视觉质量治疗效果更好。但需要更多研究和随访,以进一步验证更高方法学质量和更长干预时间的研究结果。